Access the course.

• Conduct a preoperative evaluation that includes assessment of medical and psychological conditions, concomitant medications, history of chronic pain, substance abuse disorder, and previous postoperative pain treatment regimens and responses, to guide perioperative pain management plans.
• Use a validated pain assessment tool to track responses to postoperative pain treatments and adjust treatment plans accordingly.
• Understand effective multimodal strategies and the use of different analgesic, non-opiate medications and nonpharmacologic interventions to prevent and treat pain.
• Understand the need for access to consultation with a pain specialist for those patients that have inadequately controlled perioperative pain or at high risk of inadequately controlled postoperative pain.
• Recognize the need to coordinate with patient’s prescribing clinician and continue the baseline opioid dose in the perioperative period with supplemental analgesia as needed for postoperative acute pain.
• Identify those patients who would benefit from additional consultation with a pain medicine, behavioral health, or addiction medicine specialist, clinicians should utilize telehealth options if in person consultation is not available.

Eugene Viscusi, MD (Thomas Jefferson University, Philadelphia, PA); Moderator

Jinlei Li, MD, PhD, FASA (Yale University, New Haven, CT)

Emily McQuaid-Hanson, MD (University of New Mexico, Albuquerque, NM)

Jaime Baratta, MD (Thomas Jefferson University, Philadelphia, PA)

The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists education activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Eugene Viscusi, MD (Planner and Faculty) has reported Consultant fees from Heron Therapeutics, Inc., Kowa Company, Ltd, and Salix Pharmaceuticals, a division of Bausch Health US, LLC.

All relevant relationships have been mitigated.

All other faculty, planners, reviewer, and staff have disclosed no relevant financial relationships with ineligible companies.